Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 196,794 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: ALL Clear all

Conditions: Acute Gout Flare
Interventions: Rilonacept, Indomethacin, Placebo (for Indomethacin), Placebo (for Rilonacept); Drug · Other
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 44
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mesa, Arizona + 40 more

Conditions: Psoriasis
Interventions: SFA002; Drug
Lead sponsor: SFA Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 3
States / cities: Pompano Beach, Florida • Fargo, North Dakota • Philadelphia, Pennsylvania

Conditions: Anemia
Interventions: Erythropoietin alpha, Placebo; Drug
Lead sponsor: Mathew S. Maurer; Other
Eligibility: 55 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Portal Hypertension, Liver Fibroses
Interventions: Ultrasound; Diagnostic Test
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 79 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hodgkin's Lymphoma
Interventions: MGCD0103; Drug
Lead sponsor: Mirati Therapeutics Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 3
States / cities: Chicago, Illinois • Omaha, Nebraska • Houston, Texas

Conditions: Hallux Valgus, Bunion
Interventions: Lapiplasty; Device
Lead sponsor: Treace Medical Concepts, Inc.; Industry
Eligibility: 14 Years to 58 Years
Enrollment: 183 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 7
States / cities: Greeley, Colorado • Ankeny, Iowa • Jefferson City, Missouri + 4 more

Conditions: Delirium
Interventions: Dexmedetomidine; Drug
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Ergocalciferol
Interventions: Ergocalciferol; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Healthy Volunteers
Interventions: Single High Dose Cholecalciferol, Daily Dose Cholecalciferol; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hematologic Malignancy
Interventions: Blood and/or platelet transfusion, Complete blood count (CBC) collection; Procedure
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Acute Renal Failure
Interventions: Not listed
Lead sponsor: Asha Moudgil; Other
Eligibility: 1 Year to 21 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Chronic Obstructive Lung Disease
Interventions: Breathe NIOV Ventilator; Device
Lead sponsor: Breathe Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Human Immunodeficiency Virus, HIV Seropositivity
Interventions: iTransition; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 3
States / cities: Atlanta, Georgia • Philadelphia, Pennsylvania

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma
Interventions: Radiation Therapy, Pembrolizumab, Nab-paclitaxel, Paclitaxel, Carboplatin, Gemcitabine, Biopsy, Computed Tomography, Bone Scan, Biospecimen Collection, Medical Chart Review; Radiation · Biological · Drug + 2 more
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Diabetic Neuropathy
Interventions: Neuropathy/Ulcer Homeopathic topical cream; Other
Lead sponsor: Calvary Hospital, Bronx, NY; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Cesarean Section; Complications, Wound, Dehiscence
Interventions: Silver-impregnated antimicrobial dressing; Device
Lead sponsor: Loyola University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 380 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Osteo Arthritis Knee
Interventions: Unicompartmental knee arthroplasty, Total knee arthroplasty; Procedure
Lead sponsor: Anderson Orthopaedic Research Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois • Alexandria, Virginia

Conditions: Infection, Heart Failure, COPD, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased
Interventions: Home hospitalization, Traditional inpatient hospitalization; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Hemophilia A Without Inhibitor
Interventions: Eloctate Injectable Product, Emicizumab Injection [Hemlibra]; Drug
Lead sponsor: Margaret Ragni; Other
Eligibility: 4 Months to 4 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Little Rock, Arkansas • Pittsburgh, Pennsylvania

Conditions: Bacterial Vaginosis (BV)
Interventions: LUXSOL copper containing cream, Metronidazole gel; Drug
Lead sponsor: CDA Research Group, Inc.; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Detroit, Michigan • Philadelphia, Pennsylvania

Conditions: Irritable Bowel Syndrome
Interventions: Food Elimination Diet; Other
Lead sponsor: Biomerica; Industry
Eligibility: 21 Years and older
Enrollment: 556 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 8
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Wauconda, Illinois + 4 more

Conditions: Multiple Myeloma
Interventions: Ixazomib, Placebo, Dexamethasone, Lenalidomide; Drug
Lead sponsor: Millennium Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 705 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2022
U.S. locations: 78
States / cities: Birmingham, Alabama • Chandler, Arizona • Tucson, Arizona + 75 more

Conditions: Heart Defects, Congenital, Cardiovascular Disease Other
Interventions: Physical Activity Monitoring, Tailored Exercise Prescription, Healthy Lifestyle Education, Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior; Behavioral
Lead sponsor: Jamie Jackson; Other
Eligibility: 15 Years to 25 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hypotony Ocular, Cornea Folds and Rupture of Bowman's Membrane Both Eyes, Maculopathy
Interventions: Ophthalmic imaging; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Study Utilizing Rilonacept in Gout Exacerbations

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)

Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Early Weight-Bearing After the Lapiplasty Procedure

Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients

Pilot Study: The Effect of Ergocalciferol on Plasma Mucin-1 Levels

Pilot Pharmacokinetic Study of Daily Versus Monthly High-Dose Cholecalciferol Supplementation

Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice

Carnitine, Aclycarnitine, Myocardial Function, and CRRT

Evaluation of Breathe NIOV System on Work of Breathing in Chronic Obstructive Lung Disease Patients

iTransition Development

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Effects of a Homeopathic Anti-inflammatory Topical Cream on Ulcers and Neuropathy in the Diabetic Foot

The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications

Trial of Unicompartmental Versus Total Knee Arthroplasty

Hospital-Level Care at Home for Acutely Ill Adults

The Hemophilia Inhibitor Prevention Trial

LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study

Endpoint Determination Study Protocol

IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma

Congenital Heart Disease Physical Activity Lifestyle Study V.2

Anterior Corneal Striae in Hypotony